Clinical trial · Interventional
Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective, open label, randomized and multicentric study evaluating the efficacy of an organized consultation "return home" compared to a current standard of care in patient hospitalized due to metastatic solid tumor cancer. Subject will be randomized (1:1) as described below : • Arm A (standard) : current standard of care ; connection documentation faxed to GP ( General practitioner) on the day of patient's discharge Arm B (experimental) : CREDO standard of care, organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| METASTATIC CANCER | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CREDO standard of care | Other | — | UNRESOLVED |
| current standard of care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Arm A (standard)
- interventionNames
- Other: current standard of care
- type
- EXPERIMENTAL
- label
- Arm B (experimental)
- interventionNames
- Other: CREDO standard of care
Primary outcomes (1)
- measure
- Evaluation of an organized consultation "return home" of patients with a metastatic cancer
- timeFrame
- up to 12 months
- description
- Evaluation of number of non planned consultation and hospitalization compared to current standard of care
Secondary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age \> or = 18 years old 2. Subject hospitalized in an oncology dedicated center for administration of the first chemotherapy cycle. 3. Subject with metastatic solid tumor whatever the organ 4. subject planned to be discharged home after chemotherapy administration 5. Affiliated to the French social security system. 6. Subjects must provide written informed consent prior to any study-specific procedure or assessment Exclusion Criteria: 1. Subject included in another trial evaluating the pathways care 2. Pregnant or breastfeedings women 3. Subject law protected
References
Publications (1)
- BACKGROUNDGimenez L, Grosclaude P, Druel V, Costa N, Delpierre C, Molinier L, Delord JP, Rouge Bugat ME. Study protocol of the CREDO randomised controlled trial: evaluation of a structured return home consultation for patients suffering from metastaticcancer. BMJ Open. 2023 Jan 30;13(1):e062219. doi: 10.1136/bmjopen-2022-062219. PMID 36717134